Results
(6 Answers)

Answer Explanations

  • Yes
    Expert 5
    Although widely accepted in our discipline,  I remain uncomfortable with the term MIE. I view this as the first key event in the MOA.  There is an assumption that the "MIE" is the most important determinant and if this step is identified it is the mechanism of the observed carcinogenciity.  This approach does not take into account the mutistage, multistep process of the carcinogenesis process.  Each of the Key events that follow this first key event exhibit dose response characteristics.  Therefore while the first key event  - "MIE" - starts the process subsequent key events need to be triggered for the eventual formation of the tumors.  Given my bias on the terminaology, I concur that the  evidence points to the metabolic saturation as the first key event.  
  • Yes
    Expert 6
    The evidence for the role of the parent compound in cytotoxicity, and for the key role of cell death and regenerative proliferation in cancer development by 1,4-DX strongly indicate that metabolic saturation allowing the occurrence of substantial amounts of the parent compound is in fact a molecular initiating event in the MOA. 
  • No
    Expert 4
    By convention, as above, the molecular initiating event is best described as cyp 2E1 induction. If possible, studies in cyp2E1 deficient or null animals would be extremely helpful in examining the essentiality of this key event for 1.4-DX.  This would lend additional support to its hypothesized relevance as the critically important, limiting key event in the hypothesized MOA.  As above, refinement of the PBK models, if possible, to address EPA concerns would also be helpful.

  • Yes
    Expert 2
    The initiation of oxidative stress and subsequent genomic damage that would produce hepatic growth arrest is likely an early event in the oncogenic process. 
  • No
    Expert 1
    Metabolic saturation in my mind leads to MIE but is not a MIE itself.
  • Yes
    Expert 3
    See previous comment.  
0
Expert 2
05/13/2024 12:25
I very much agree with Expert 5. The term MIE can be greatly misleading for the multistep process of carcinogenesis and certainly for this case. 
0
Expert 4
05/15/2024 09:34
The molecular initiating event is defined as "a specialised type of key event that represents the initial point of chemical/stressor interaction at the molecular level within the organism that results in a perturbation that starts the AOP/MOA" (i.e., the first key event).  It was introduced in the context of AOPs to incorporate evolving information on molecular level interactions.  I don't believe that there was any intent to confer special significance to the MIE as a more or most important determinant within a described pathway though it may be being interpreted this way.  As far as I'm aware, the terminology was developed in full recognition of the need to trigger subsequent key events (each with relevant dose-response relationships).
0
Expert 6
05/21/2024 10:19
A molecular initiating event (MIE) sounds like a type of biochemical effect or interaction. The saturation of metabolic clearance most probably results in such an event, but should not be called an MIE.
0
Expert 3
05/23/2024 16:48
I concur with comments of expert 4 and responding debate of experts 2 and 4.  I view the inability of the organism to metabolically "handle" the high doses presented to it through its normal biological status as representing evidence of a chemically-induced stressor event (which can be readily detected by a dose-disproportionate shift in plasma toxicokinetics) , i.e., the organism senses the dose challenge as being outside of its existing homeostatic capabilities and responds to restore that homeostasis by altering the capacity of its detoxification resources.  If the responding and biologically-limiting homeostatic defense mechanisms remain overwhelmed by a very high dose stressor (as is for DX), it moves the organism from a condition of adaptive "eustress" to toxicologically important "distress" (Sies  http://dx.doi.org/10.1016/j.redox.2016.12.035).  Although Sies developed the eustress/distress concept specifically for oxidative stress, its fundamental underlying principles reasonably extend to metabolic saturation
0
Expert 1
06/05/2024 15:51
yes

I agree with expert 4, MIE have been defined as part of the AOP process for toxicology outcomes. The AOP for Dioxane includes this and the citation below support this hypothesis. Again, ROS is produced (Totsuka et al., 2020) at high dose associated with metabolic saturation. ROS based MOA is a threshold based MOA (AOP 296) and will enable a risk assessment based BMD and a POD to generate human equivalent concentrations and assess margin of exposures. 

Totsuka Y, Maesako Y, Ono H, Nagai M, Kato M, Gi M, Wanibuchi H, Fukushima S, Shiizaki K, Nakagama H. Comprehensive analysis of DNA adducts (DNA adductome analysis) in the liver of rats treated with 1,4-dioxane. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(5):180-187. doi: 10.2183/pjab.96.015. PMID: 32389918; PMCID: PMC7248212.
Comments are closed for this page.